Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


3 Acta Obstet Gynecol Scand
5 Am J Obstet Gynecol
1 Aust N Z J Obstet Gynaecol
2 BMC Cancer
1 Cancer Lett
1 Curr Opin Urol
1 Eur J Cancer
3 Eur J Obstet Gynecol Reprod Biol
2 Fertil Steril
2 Gynecol Oncol
1 Hum Reprod
1 Int J Cancer
20 Int J Gynaecol Obstet
1 Int J Oncol
1 J Clin Endocrinol Metab
1 J Clin Oncol
10 Obstet Gynecol
2 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Obstet Gynecol Scand

  1. BHATIA K, Columb M, Narayan B, Wilson A, et al
    Critical care, maternal and neonatal outcomes of pregnant women with COVID-19 admitted to eight intensive care units during the wildtype, alpha and delta waves of the pandemic across the North West of England-a retrospective review.
    Acta Obstet Gynecol Scand. 2023 Sep 20. doi: 10.1111/aogs.14681.
    PubMed         Abstract available

  2. PASQUINI L, Masini G, Cagninelli G, Polimeno T, et al
    Small-for-gestational-age fetus diagnosed in the second trimester: Possible etiologies and short-term neonatal outcomes.
    Acta Obstet Gynecol Scand. 2023 Sep 18. doi: 10.1111/aogs.14679.
    PubMed         Abstract available

  3. SHANG JH, Huang CX, Zheng Q, Feng JL, et al
    Imaging features, clinical characteristics and neonatal outcomes of pregnancy luteoma: A case series and literature review.
    Acta Obstet Gynecol Scand. 2023 Sep 14. doi: 10.1111/aogs.14672.
    PubMed         Abstract available

    Am J Obstet Gynecol

  4. HAJRI T, Massoud M, Vergne M, Descargues P, et al
    Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
    Am J Obstet Gynecol. 2023 Sep 16:S0002-9378(23)00612.
    PubMed         Abstract available

  5. LO FARO V, Johansson T, Johansson A
    The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors-a prospective cohort study of 240,000 women in the UK Biobank.
    Am J Obstet Gynecol. 2023 Sep 19:S0002-9378(23)00618.
    PubMed         Abstract available

  6. KAUFFMAN TL, Irving SA, Brooks N, Vesco KK, et al
    Postmenopausal bleeding after COVID-19 vaccination.
    Am J Obstet Gynecol. 2023 Sep 17:S0002-9378(23)00613.
    PubMed         Abstract available

  7. GARDOSI J, Hugh O
    High BMI pregnancies require serial assessment of fetal size and growth velocity.
    Am J Obstet Gynecol. 2023 Sep 16:S0002-9378(23)00617.

  8. L C
    In obese mothers fetal growth decline may reflect placental dysfunction and high stillbirth risk.
    Am J Obstet Gynecol. 2023 Sep 16:S0002-9378(23)00616.

    Aust N Z J Obstet Gynaecol

  9. WILLIAMS L, Henry C, Simcock B, Filoche S, et al
    Increasing incidence of endometrial cancer in Aotearoa New Zealand: Health professionals' perspective.
    Aust N Z J Obstet Gynaecol. 2023 Sep 22. doi: 10.1111/ajo.13751.
    PubMed         Abstract available

    BMC Cancer

  10. YU Y, Zhang Y, Li Z, Dong Y, et al
    An EMT-related genes signature as a prognostic biomarker for patients with endometrial cancer.
    BMC Cancer. 2023;23:879.
    PubMed         Abstract available

  11. LI J, Li X, Quan C, Li X, et al
    Genomic profile of Chinese patients with endometrial carcinoma.
    BMC Cancer. 2023;23:888.
    PubMed         Abstract available


  12. WISE J
    Ovarian cancer: NICE recommends expanding availability of genetic testing.
    BMJ. 2023;382:2111.

  13. PERUMAL N, Wang D, Darling AM, Liu E, et al
    Suboptimal gestational weight gain and neonatal outcomes in low and middle income countries: individual participant data meta-analysis.
    BMJ. 2023;382:e072249.
    PubMed         Abstract available

  14. TANNE JH
    Women denied abortions for dangerous pregnancy problems sue three US states.
    BMJ. 2023;382:p2137.

  15. MARTIN JS, Masinde J, Canizares A, Irfan S, et al
    Menstrual health must be prioritised in global policies.
    BMJ. 2023;382:2109.

    Cancer Lett

  16. VENKATA PP, Jayamohan S, He Y, Alejo S, et al
    Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.
    Cancer Lett. 2023 Sep 13:216383. doi: 10.1016/j.canlet.2023.216383.
    PubMed         Abstract available

    Curr Opin Urol

  17. GRAF S, Somani BK
    Ureterorenoscopy for stone disease in pregnancy: a literature review and update.
    Curr Opin Urol. 2023 Sep 20. doi: 10.1097/MOU.0000000000001133.
    PubMed         Abstract available

    Eur J Cancer

  18. LEARY A, Oaknin A, Trigo JM, Moreno V, et al
    Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours.
    Eur J Cancer. 2023;192:113259.
    PubMed         Abstract available

    Eur J Obstet Gynecol Reprod Biol

  19. CHEUNG CT, Jayasekara M, Hussain M, Raman N, et al
    Synchronous bilateral ovarian torsion followed by recurrent unilateral torsion in a patient undergoing fertility treatment: A case report and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2023;290:60-66.
    PubMed         Abstract available

  20. MONTAGUTI E, Youssef A, Fiorentini M, Bernardi V, et al
    A peculiar case of vasa previa: Placental lake and fetal bridge vessel.
    Eur J Obstet Gynecol Reprod Biol. 2023 Sep 13:S0301-2115(23)00719.

  21. SOOBRYAN N, Kumar A, Moodley J, Mackraj I, et al
    The role and expression of pro/antiangiogenic factors and microRNAs in gestational hypertension and pre-eclampsia.
    Eur J Obstet Gynecol Reprod Biol. 2023;290:38-42.
    PubMed         Abstract available

    Fertil Steril

  22. CHAE-KIM J, Doyle N, Jahandideh S, O'Brien JE, et al
    Evaluating the Endometrial Receptivity Assay: a nested diagnostic accuracy study within the Synchrony randomized clinical trial.
    Fertil Steril. 2023 Sep 13:S0015-0282(23)01862.
    PubMed         Abstract available

  23. VAN WELY M
    Series of overviews on miscarriage and recurrent miscarriage.
    Fertil Steril. 2023 Sep 16:S0015-0282(23)01872.
    PubMed         Abstract available

    Gynecol Oncol

  24. MARSH LA, Kim TH, Zhang M, Kubalanza K, et al
    Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival.
    Gynecol Oncol. 2023;177:173-179.
    PubMed         Abstract available

  25. BLACK KA, Nelson G, Goucher N, Foley J, et al
    Effect of transversus abdominis plane block on postoperative outcomes in gynecologic oncology patients managed on an Enhanced Recovery After Surgery pathway.
    Gynecol Oncol. 2023;178:1-7.
    PubMed         Abstract available

    Hum Reprod

  26. YI Y, Fu J, Xie S, Zhang Q, et al
    Association between ovarian reserve and spontaneous miscarriage and their shared genetic architecture.
    Hum Reprod. 2023 Sep 15:dead180. doi: 10.1093.
    PubMed         Abstract available

    Int J Cancer

  27. HUANG J, Chan SC, Fung YC, Pang WS, et al
    Global incidence, risk factors and trends of vulvar cancer: A country-based analysis of cancer registries.
    Int J Cancer. 2023 Aug 2. doi: 10.1002/ijc.34655.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  28. QIU L, Lv M, Chen L, Chen Z, et al
    Comparison of two emergency cervical cerclage techniques in twin pregnancies: A retrospective cohort study matched with cervical dilation.
    Int J Gynaecol Obstet. 2023 Sep 15. doi: 10.1002/ijgo.15081.
    PubMed         Abstract available

  29. MARQUES LJP, Silva ZPD, Alencar GP, Paixao ESD, et al
    Prevalence and risk of stillbirth according to biologic vulnerability phenotypes in the municipality of Sao Paulo, Brazil: A population-based cohort study.
    Int J Gynaecol Obstet. 2023 Sep 15. doi: 10.1002/ijgo.15102.
    PubMed         Abstract available

  30. TURCO LC, Raimondo D, Raffone A, Raimondo I, et al
    Horizontal versus vertical direction of posterior vaginal wall suture after eradication of rectovaginal endometriosis: A multicenter study.
    Int J Gynaecol Obstet. 2023 Sep 16. doi: 10.1002/ijgo.15109.
    PubMed         Abstract available

  31. TYAGI A, Bodh P, Mohta M, Gupta B, et al
    Weight-based versus fixed dose oxytocin infusion for preventing uterine atony during cesarean section in laboring patients: A randomized trial.
    Int J Gynaecol Obstet. 2023 Sep 16. doi: 10.1002/ijgo.15138.
    PubMed         Abstract available

  32. LIN H, Chen WH, Chen CY, Yang YH, et al
    Does repetitive dilatation and curettage or hysteroscopic biopsy in patients treated with progestins for endometrial hyperplasia or carcinoma affect subsequent fetomaternal outcomes? A population-based study using the National Health Insurance Researc
    Int J Gynaecol Obstet. 2023 Sep 18. doi: 10.1002/ijgo.15108.
    PubMed         Abstract available

  33. CALLANDER EJ, Tarnow-Mordi W, Morton R, Mol BW, et al
    Intrapartum use of sildenafil citrate to prevent fetal compromise and emergency operative birth in term pregnancies in the United Kingdom and Australia: A preliminary cost-effectiveness analysis.
    Int J Gynaecol Obstet. 2023 Sep 18. doi: 10.1002/ijgo.15135.
    PubMed         Abstract available

  34. CARUSO E
    The hyper-regulation of abortion care in Italy.
    Int J Gynaecol Obstet. 2023 Sep 19. doi: 10.1002/ijgo.15150.
    PubMed         Abstract available

  35. ZHANG D, Gao J
    Neonatal PURA syndrome mimicking cervical spinal cord injury after a cesarean section for a breech presentation: A case report.
    Int J Gynaecol Obstet. 2023 Sep 19. doi: 10.1002/ijgo.15094.

  36. BARTELS HC, Walsh D, Nieto-Calvache AJ, Lalor J, et al
    Anesthesia and postpartum pain management for placenta accreta spectrum: The healthcare provider perspective.
    Int J Gynaecol Obstet. 2023 Sep 19. doi: 10.1002/ijgo.15096.
    PubMed         Abstract available

  37. BARTELS HC, Lalor JG, Walsh D, Nieto-Calvache AJ, et al
    Anesthesia and postpartum pain management for placenta accreta spectrum: The patient perspective and recommendations for care.
    Int J Gynaecol Obstet. 2023 Sep 19. doi: 10.1002/ijgo.15125.
    PubMed         Abstract available

  38. XU J, Tang Y, Peng B, Zhang WH, et al
    Effect of low-molecular-weight heparin on placenta-mediated fetal growth restriction in a tertiary referral hospital: A 7-year retrospective cohort study.
    Int J Gynaecol Obstet. 2023 Sep 19. doi: 10.1002/ijgo.15098.
    PubMed         Abstract available

  39. SIMON J, Thisse J, Chabert C, Barasinski C, et al
    Research procedure acceptability through women during pregnancy and postpartum: A pilot study.
    Int J Gynaecol Obstet. 2023 Sep 19. doi: 10.1002/ijgo.15104.
    PubMed         Abstract available

  40. WEISS M, Baumfeld Y, Rotem R, Gedalia Y, et al
    The impact of a previous cesarean section on the risk of perioperative and postoperative complications during vaginal hysterectomy.
    Int J Gynaecol Obstet. 2023 Sep 20. doi: 10.1002/ijgo.15105.
    PubMed         Abstract available

  41. SEPENU P, Swarray-Deen A, Scott A, Boafor TK, et al
    Disseminated adult Wilms tumor in pregnancy: Leveraging multidisciplinary care in a low-resource setting.
    Int J Gynaecol Obstet. 2023 Sep 20. doi: 10.1002/ijgo.15157.
    PubMed         Abstract available

  42. JIAMSET I, Uttraporn P, Suphasynth Y
    Comparative outcomes between transvaginal endoscopic hysterectomy and total laparoscopic hysterectomy in patients with benign uterine disease: A single-center, retrospective, cohort, interrupted time-series study.
    Int J Gynaecol Obstet. 2023 Sep 20. doi: 10.1002/ijgo.15144.
    PubMed         Abstract available

  43. RAFFONE A, Raimondo D, Neola D, Travaglino A, et al
    Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2023 Sep 21. doi: 10.1002/ijgo.15136.
    PubMed         Abstract available

  44. REIJNTJES B, Eising M, Kleppe M, Geuken E, et al
    The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Int J Gynaecol Obstet. 2023;163:140-147.
    PubMed         Abstract available

  45. ZHAN H, Zhang H, Sun J, Wang W, et al
    Refractory florid cystic endosalpingiosis: A case report with 5 years follow up and literature review.
    Int J Gynaecol Obstet. 2023;163:44-50.
    PubMed         Abstract available

  46. HAMAR B, Teutsch B, Hoffmann E, Hegyi P, et al
    Trichomonas vaginalis infection is associated with increased risk of cervical carcinogenesis: A systematic review and meta-analysis of 470 000 patients.
    Int J Gynaecol Obstet. 2023;163:31-43.
    PubMed         Abstract available

  47. AYHAN A, Tunc M, Akilli H, Haberal N, et al
    Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.
    Int J Gynaecol Obstet. 2023 Sep 22. doi: 10.1002/ijgo.15141.
    PubMed         Abstract available

    Int J Oncol

  48. DENG F, Fu M, Zhao C, Lei J, et al
    Calcium signals and potential therapy targets in ovarian cancer (Review).
    Int J Oncol. 2023;63:125.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  49. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    PubMed         Abstract available

    J Clin Oncol

  50. HOREWEG N, Nout RA, Jurgenliemk-Schulz IM, Lutgens LCHW, et al
    Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.
    J Clin Oncol. 2023;41:4369-4380.
    PubMed         Abstract available


  51. CHRIST JP, Navarro VM, Reed SD
    Nonhormonal Therapies for Menopausal Vasomotor Symptoms.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.15965.

  52. FLEURANT E, Mokashi M, Simon MA
    Over-the-Counter Progestin-Only Oral Contraceptives.
    JAMA. 2023 Sep 15. doi: 10.1001/jama.2023.17781.

  53. BARRY MJ, Nicholson WK, Silverstein M, Cabana MD, et al
    Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement.
    JAMA. 2023;330:1074-1082.
    PubMed         Abstract available

  54. HARRIS E
    Abortions in States Without Bans Surge Post-Roe.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17817.

  55. HARRIS E
    Blot Clot Risk Higher When Pain Relievers Used With Hormonal Contraception.
    JAMA. 2023 Sep 20. doi: 10.1001/jama.2023.17823.

  56. DENOBLE AE, Pettker CM
    Hypertension Screening in Pregnancy: Remembering the Basics, Charting the Future.
    JAMA. 2023;330:1040-1041.

  57. JIN J
    Screening for High Blood Pressure Disorders During Pregnancy.
    JAMA. 2023;330:1107.

  58. HENDERSON JT, Webber EM, Thomas RG, Vesco KK, et al
    Screening for Hypertensive Disorders of Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;330:1083-1091.
    PubMed         Abstract available

    Obstet Gynecol

  59. VOLESKY-AVELLANEDA KD, Laurie C, Tsyruk-Romano O, El-Zein M, et al
    Human Papillomavirus Detectability and Cervical Cancer Prognosis: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023 Sep 14. doi: 10.1097/AOG.0000000000005370.
    PubMed         Abstract available

  60. GOFFMAN D, Rood KM, Bianco A, Biggio JR, et al
    Real-World Utilization of an Intrauterine, Vacuum-Induced, Hemorrhage-Control Device.
    Obstet Gynecol. 2023 Sep 14. doi: 10.1097/AOG.0000000000005366.
    PubMed         Abstract available

  61. NNOLI A
    Historical Primer on Obstetrics and Gynecology Health Inequities in America: A Narrative Review of Four Events.
    Obstet Gynecol. 2023;142:779-786.
    PubMed         Abstract available

  62. ARKERSON BJ, Finneran MM, Harris SR, Schnorr J, et al
    Remote Monitoring Compared With In-Office Surveillance of Blood Pressure in Patients With Pregnancy-Related Hypertension: A Randomized Controlled Trial.
    Obstet Gynecol. 2023;142:855-861.
    PubMed         Abstract available

  63. NAJOR A, Melson V, Lyu J, Fadadu P, et al
    Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review.
    Obstet Gynecol. 2023;142:967-977.
    PubMed         Abstract available

  64. BURNS RN
    Houston, We Have a Problem: How Changes in Gynecologic Oncology Represent Broader Concerns for the Future of Obstetrics and Gynecology.
    Obstet Gynecol. 2023;142:992-993.

    Houston, We Have a Problem: How Changes in Gynecologic Oncology Represent Broader Concerns for the Future of Obstetrics and Gynecology.
    Obstet Gynecol. 2023;142:993.

  66. TEMKIN SM, Terplan M
    Levels of Gynecologic Care: A Task Force Consensus Statement.
    Obstet Gynecol. 2023;142:993-994.

  67. TUMIN D, Whiteside JL
    Competitiveness of Obstetrics and Gynecology Residency Programs and Applicants.
    Obstet Gynecol. 2023;142:994-995.

  68. Association of the Cervicovaginal Microbiome With Contraceptive Methods in Hispanic Women Living in Puerto Rico [ID: 1376364]: Correction.
    Obstet Gynecol. 2023;142:996.

    PLoS One

  69. WANG S, Wang Y, Zhuang J, Wu Y, et al
    Prognostic significance of index (LANR) composed of preoperative lymphocytes, albumin, and neutrophils in patients with stage IB-IIA cervical cancer.
    PLoS One. 2023;18:e0290905.
    PubMed         Abstract available

  70. MOATAMED NA, Vahdatshariatpanahi S, Gjertson DW, Sachs CR, et al
    Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers.
    PLoS One. 2023;18:e0291361.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.